An underground market for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where communities with thousands of members share comparison photos, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.
Some experts said the popularity for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Service Response and Content Elimination
According to TikTok, the platform has removed violative material and prohibited associated hashtags and query recommendations. The organization said it was committed to maintaining the service safe and investing in strengthening compliance measures.
Digital Marketplace Activities
Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays groups with thousands of members, filled with images of weight loss, positive reviews and detailed instructions for preparing or administering at home.
Within moments of entering one community, a vendor posted WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.
Product Information and Pricing
Within these communities, posts show dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for the messaging service stated it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the surge in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.
Her team has previously seen individuals harmed by personal administration from unverified sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to possibly significant medical dangers”.
